Streetbeat News

Regulatory

FOXO

FOXO Technologies Inc. (NYSE:FOXO) has received an Issue Notification from the United States Patent & Trademark Office (USPTO) for a patent that uses machine learning to enable the commercialization of epigenetic biomarkers. This builds on previous Notices of Allowance issued by the USPTO for two related patents. The patents support the use of machine learning in estimating health aspects and filling in missing or unreliable epigenetic values. The company has generated epigenetic data for over 13,000 individuals to support these patents.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:02 pm

MRK

Merck & Company has received a positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) for its drug KEYTRUDA, in combination with chemotherapy, as a first-line treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma expressing PD-L1 (CPS ≥1).

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 11:48 am

AMLX

Amylyx Pharmaceuticals has received a negative opinion from the Committee for Medicinal Products for Human Use (CHMP) on its marketing authorisation application for AMX0035 for the treatment of ALS in the European Union. The final decision from the European Commission is expected by the end of 2023. The PHOENIX Phase 3 trial topline results are on track for mid-2024.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 11:46 am

AMD

BABA

NVDA

Alibaba's stock is trading lower due to concerns about China's economic rebound as producer and consumer prices in mainland China missed market expectations. The U.S. is preparing to close a loophole that allowed Chinese companies to access American AI chips through overseas units, which could impact Nvidia and Advanced Micro Devices. On a positive note, Alibaba's logistics arm, Cainiao Network, launched a half-day express delivery service in collaboration with Tmall Supermarket in Beijing.

Portfolio Pulse from Anusuya Lahiri

October 13, 2023 | 11:45 am

EIS

SPY

Israel's Defense Minister, Gallant, has announced plans to topple the Hamas government and destroy its military capability.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 11:43 am

PFE

The Committee for Medicinal Products for Human Use (CHMP) has recommended conditional marketing authorization in the European Union for Elrexfio, a treatment for adults with relapsed and refractory multiple myeloma. The news may impact Pfizer Inc. (PFE), which could be mentioned in the article.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 11:30 am

ACI

KR

California Attorney General Rob Bonta has raised concerns over the planned acquisition of Albertsons Companies Inc (NYSE:ACI) by Kroger Company (NYSE:KR), valued at $24.5 billion. The deal is under scrutiny due to potential negative impacts on California residents, including increased consumer prices and reduced compensation to local farmers. The companies had proposed selling over 400 grocery outlets to C&S Wholesale Grocers to address regulatory concerns.

Portfolio Pulse from Shivani Kumaresan

October 13, 2023 | 11:22 am

FXI

China's Premier has announced that the country's economy is on the path of recovery and improvement, according to state media reports cited by Reuters.

Portfolio Pulse from Charles Gross

October 13, 2023 | 11:18 am

EH

EHang shares resumed trading and surged 82% after the company announced it has successfully obtained a type certificate for its EH216-S passenger-carrying UAV system from the Civil Aviation Administration of China.

Portfolio Pulse from Charles Gross

October 13, 2023 | 11:08 am

ELDN

Eledon Pharmaceuticals will present new data from its ongoing open-label Phase 1b trial of Tegoprubart for the prevention of rejection in kidney transplantation at the American Society of Nephrology's Kidney Week 2023 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 11:07 am